Makoto Murakami Selected Research

Ichthyosis (Xeroderma)

1/2019	The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function.
1/2017	PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Murakami Research Topics

Disease

40	Inflammation (Inflammations) 05/2024 - 03/2002
27	Neoplasms (Cancer) 05/2024 - 05/2003
15	Atherosclerosis 01/2023 - 03/2002
11	Anaphylaxis (Anaphylactic Shock) 01/2019 - 06/2007
10	Neoplasm Metastasis (Metastasis) 10/2022 - 11/2003
8	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 05/2003
7	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2016
7	Hyperplasia 12/2023 - 03/2006
7	Hypersensitivity (Allergy) 04/2022 - 08/2004
6	Carcinogenesis 01/2022 - 05/2003
5	Obesity 01/2023 - 07/2014
5	Infections 01/2022 - 01/2006
5	Stomach Neoplasms (Stomach Cancer) 08/2020 - 10/2005
4	Asthma (Bronchial Asthma) 01/2024 - 06/2010
4	Insulin Resistance 01/2023 - 01/2016
4	Dyspepsia (Indigestion) 01/2021 - 01/2018
3	Chronic Pancreatitis 01/2021 - 01/2018
3	Rheumatoid Arthritis 04/2020 - 08/2004
3	Pain (Aches) 01/2019 - 08/2004
3	Carcinoma (Carcinomatosis) 03/2018 - 06/2002
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2007
3	Atopic Dermatitis (Atopic Eczema) 12/2011 - 04/2002
2	Lymphoma (Lymphomas) 05/2024 - 01/2022
2	Eosinophilia 01/2024 - 11/2005
2	Skin Abnormalities 12/2023 - 04/2011
2	Pathologic Constriction (Stenosis) 07/2023 - 05/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2013
2	Ischemia 12/2022 - 01/2011
2	Dermatitis 10/2022 - 06/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 03/2018
2	Fibrosis (Cirrhosis) 01/2022 - 10/2020
2	COVID-19 01/2022 - 04/2021
2	Skin Diseases (Skin Disease) 01/2022 - 01/2018
2	Contact Dermatitis (Eczema, Contact) 01/2021 - 06/2013
2	Osteoarthritis 04/2020 - 01/2008
2	Metaplasia 07/2019 - 10/2005
2	Ichthyosis (Xeroderma) 01/2019 - 01/2017
2	Colitis 01/2017 - 03/2016
2	Edema (Dropsy) 02/2014 - 11/2003

Drug/Important Bio-Agent (IBA)

34	Secretory Phospholipases A2IBA 01/2024 - 03/2002
29	LipidsIBA 05/2024 - 10/2003
26	EnzymesIBA 12/2023 - 03/2002
18	Phospholipases (Phospholipase)IBA 10/2023 - 06/2002
10	CytokinesIBA 01/2024 - 12/2003
10	EicosanoidsIBA 01/2022 - 03/2002
9	Phospholipases A2 (Phospholipase A2)IBA 01/2024 - 11/2007
8	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024 - 08/2002
8	Dinoprostone (PGE2)FDA Link 03/2018 - 05/2003
7	ProstaglandinsIBA 10/2020 - 12/2003
7	Prostaglandin-E SynthasesIBA 03/2018 - 05/2003
7	Group X Phospholipases A2IBA 03/2016 - 06/2002
6	Group II Phospholipases A2IBA 01/2016 - 04/2002
5	Fatty Acids (Saturated Fatty Acids)IBA 05/2024 - 03/2016
5	Immunoglobulin E (IgE)IBA 01/2024 - 06/2007
5	LeukotrienesIBA 11/2022 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2004
4	Arachidonic Acid (Vitamin F)IBA 05/2024 - 10/2011
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2012
4	Imiquimod (Aldara)FDA LinkGeneric 12/2023 - 01/2020
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2020 - 10/2004
4	LipopolysaccharidesIBA 03/2015 - 04/2002
4	IsoenzymesIBA 11/2006 - 03/2002
3	AcidsIBA 10/2023 - 10/2016
3	Histones (Histone)IBA 10/2023 - 05/2007
3	CalpainIBA 01/2023 - 12/2011
3	Leukotriene B4IBA 11/2022 - 10/2016
3	protectin D1IBA 11/2022 - 03/2013
3	Prostaglandin D2IBA 01/2022 - 02/2012
3	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 12/2011
3	AMP-Activated Protein KinasesIBA 01/2017 - 09/2013
3	InterleukinsIBA 05/2009 - 10/2004
3	Prostaglandins EIBA 12/2005 - 12/2003
2	OvalbuminIBA 01/2024 - 08/2013
2	LysophospholipidsIBA 01/2024 - 01/2022
2	Choline (Choline Chloride)IBA 01/2023 - 01/2023
2	Methionine (L-Methionine)FDA Link 01/2023 - 01/2023
2	Glycerophospholipids (Phosphoglycerides)IBA 12/2022 - 01/2019
2	N-acylethanolaminesIBA 12/2022 - 01/2022
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 11/2022 - 01/2020
2	prostaglandin D2 receptorIBA 01/2022 - 04/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
2	asapiprantIBA 01/2022 - 04/2021
2	Insulin (Novolin)FDA Link 10/2020 - 04/2011
2	Z 338IBA 01/2020 - 01/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 03/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2018 - 10/2004
2	Interleukin-6 (Interleukin 6)IBA 03/2018 - 03/2015
2	Sirtuin 1IBA 01/2018 - 01/2017
2	Dextran SulfateIBA 01/2017 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 06/2015
2	Oxygen (Dioxygen)IBA 09/2015 - 03/2015
2	varespladibIBA 03/2015 - 03/2013
2	AntibodiesIBA 07/2014 - 10/2004

Therapy/Procedure

10	Therapeutics 07/2023 - 11/2003
6	Drug Therapy (Chemotherapy) 07/2023 - 10/2005
4	Lymph Node Excision (Lymph Node Dissection) 07/2023 - 11/2003
3	Pancreaticoduodenectomy 07/2023 - 07/2016
3	Colectomy 01/2018 - 11/2003
3	Glycemic Control 07/2012 - 01/2009
2	Adjuvant Chemotherapy 08/2020 - 10/2017